tirzepatide patent expiry 2036 eli lilly Lilly's Shows Promise in Treating Fatty Liver Disease Eli Lilly weight loss drug

GLP-1 medications are designed to promote satiety and aid weight loss by slowing gastric emptying and reducing appetite, but they may also cause side effects like nausea, bloating, and digestive discomfort

Decisions about starting, stopping or switching treatment should be made by the doctor who prescribed it, because they need to weigh the full benefits and risks for your individual situation

* Clinical studies still to be conducted

Novo Nordisk, the maker of popular weight-loss drugs like Wegovy and Ozempic, claims that Eli Lilly's advertising campaigns are misleading consumers by overstating the efficacy of its own GLP-1 drugs in comparison to Novo Nordisk's products